Prof. Paulo Eduardo Ocke Reis, PhD - Fluminense Federal University (UFF) - Prof.

Prof. Paulo Eduardo Ocke Reis

PhD

Fluminense Federal University (UFF)

Prof.

Rio de Janeiro, Rio de Janeiro | Brazil

Main Specialties: Vascular & Interventional Radiology, Vascular Surgery

Additional Specialties: Vascular & Endovascular Surgery

ORCID logohttps://orcid.org/0000-0001-5450-6806


Top Author

Prof. Paulo Eduardo Ocke Reis, PhD - Fluminense Federal University (UFF) - Prof.

Prof. Paulo Eduardo Ocke Reis

PhD

Introduction

Paulo Eduardo Ocke Reis, MD, PhD
https://www.researchgate.net/profile/Paulo_Ocke_Reis



Short Curriculum Vitae

Lattes---http://lattes.cnpq.br/0252127105290905

Editor-in-Chief Journal of Vascular & Endovascular Therapy
http://vascular-endovascular-therapy.imedpub.com/editors.php

EJVES Short Reports Editorial Board - Associate Editor
https://www.ejvesreports.com/content/edboard


Education
Oct 2004 – Mar 2005 Albert Einstein College of Medicine
FELLOW, Vascular Researcher
New York City, United States
2003- ESPECIALIST IN ENDOVASCULAR SURGERY-SBACV/AMB/SBR
2001- ESPECIALIST IN VASCULAR SURGERY-SBACV/AMB
Jun 2001 – Jul 2001 Yale University
VISITOR, VASCULAR SURGERY
New Haven, United States
Mar 1996 – Mar 1998 HOSPITAL CENTRAL DA POLICIA, BRAZIL
RESIDÊNCIA MÉDICA, CIRURGIA VASCULAR
RIO DE JANEIRO, Brazil
Mar 1988 – Mar 1990 HOSPITAL UNIVERSITÁRIO ANTONIO PEDRO
RESIDÊNCIA, CIRURGIA GERAL
Rio de Janeiro, Rio de Janeiro, Brazil
PhD Thesis
Paulo Eduardo Ocke Reis: IMPACTO DA TERAPIA ANGIOGÊNICA PARA O TRATAMENTO DA ISQUEMIA CRÍTICA DE MEMBROS INFERIORES EM MODELO ANIMAL. 01/2009, Degree: PhD, Supervisor: Prof. Dr. Radovan Borojevic, Prof. Dr. Sang Won Han


Brazilian College of Surgeons
Paulo Eduardo Ocke Reis: TRATAMENTO PERCUTÂNEO DO TRAUMA VASCULAR. 01/2001, Degree: TITULAR DO CBC, Supervisor: CBC COLÉGIO BRASILEIRO DE CIRURGIÕES

Research Experience
Aug 2011 – present Professor of Vascular Surgery
Federal University Fluminense, Department of Specialized and General Surgery (MCG)
Niterói, Brazil
Mar 2005 – Sep 2009 PhD Student
Federal University of Rio de Janeiro, Department of Histology e Embryology
Rio de Janeiro, Brazil
PhD- UFRJ , Program of Pós -Graduation in Morphological Ciências – PhD Thesis "Impact of Angiogenic Therapy for isquemic legs in animal model "
Mar 2005 – Sep 2009 PhD Student
Federal University of de São Paulo, Department of Biophysics Cirtergen
São Paulo, Brazil
PhD- UFRJ, Program Pós -Graduation in Morphological Ciências –PhD Thesis "Impact of Angiogenic Therapy for isquemic legs in animal model "
Oct 2004 – Mar 2005 Fellowship
Albert Einstein College of Medicine, Department of Vascular-Interventional Radiology
New York City, United States
Mar 2004 – Mar 2009 PhD Student
Federal University of Rio de Janeiro, Department of Histology and Embryology
,
Jun 2001 – Jul 2001 Vascular Surgery Student
Yale University, Vascular Biology & Therapeutics
New Haven, United States
Mar 1994 – present Medical Doctor
Universidade Federal Fluminense,
Niterói, Brazil
Coordinator of the Vascular Service from HUAP/UFF since 2001.

Primary Affiliation: Fluminense Federal University (UFF) - Rio de Janeiro, Rio de Janeiro , Brazil

Specialties:

Additional Specialties:

Research Interests:


View Prof. Paulo Eduardo Ocke Reis’s Resume / CV

Education

Jan 2004 - Jan 2009
Universidade Federal do Rio de Janeiro
Doutorado em Ciências Morfológicas (Conceito CAPES 6). Universidade Federal do Rio de Janeiro, UFRJ, Brasil. Título: IMPACTO DA TERAPIA ANGIOGÊNICA PARA TRATAMENTO DA ISQUEMIA CRÍTICA DE MEMBROS INFERIORES EM ANIMAIS., Ano de obtenção: 2009.
Oct 2004 - Mar 2005
Yeshiva University Albert Einstein College of Medicine
Vascular Researcher
Jun 2001 - Jul 2001
Yale University
VISITOR
VASCULAR SURGERY
Mar 1996 - Mar 1998
Hospital Central da Polícia Militar
Residência em cirurgia Vascular
Cirurgia Vascular
Mar 1988 - Mar 1990
Hospital Universitário Antônio Pedro
Residência de cirurgia Geral
Jan 2011
Universidade Federal Fluminense
Professor adjunto de cirurgia Vascular
Departamento de Cirurgia Geral e Especializada
Jan 2001
Sociedade Brasileira de Angiologia e Cirurgia Vascular
Especialista em Cirurgia Vascular pela SBACV/AMB
Jan 2001
Sociedade Brasileira de Angiologia e Cirurgia Vascular
Especialista em Cirurgia Vascular pela SBACV/AMB

Experience

Universidade Federal Fluminense
Chefe do Serviço de cirurgia Vascular
Departamento de cirurgia Geral e Especializada

Publications

29Publications

204Reads

50Profile Views

1PubMed Central Citations

Energy level: an important determinant of success in vascular surgery.

J Vasc Bras 2019 8;18:e20190029. Epub 2019 Apr 8.

Universidade Federal Fluminense - UFF, Departamento de Cirurgia Geral e Especializada, Rio de Janeiro, RJ, Brasil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/1677-5449.180001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628884PMC
April 2019

Opportunities in the International Consortium of Vascular Registries

Journal of Vascular and Endovascular Therapy

It is difficult for vascular surgeons to recognize patternsassociated with bad outcomes because they occur infrequently even in a busy practice. This makes quality improvementdifficult and suggests the need for collaborative registries that can analyze thousands of patients to discern and incent bestpractices. Hertzer and colleagues first demonstrated the feasibility of a regional vascular registry in 1979 and emphasized that we must measure our performance in order to improve it .

View Article
December 2018
7 Reads

Building the Future in Vascular Surgery

Journal of Vascular and Endovascular Surgery

https://publons.com/publon/988104/

View Article
2017
3 Reads

Impact of Angiogenic Therapy in the Treatment of Critical Lower Limb Ischemia in an Animal Model.

Vascular and endovascular surgery

Angiogenic therapies for critical limb ischemia were tested in a mouse model. The mice were anesthetized and their femoral arteries were ligated. The animals were treated with bone marrow mononuclear cells (BMMCs) alone, BMMCs combined with plasmid vector encoding granulocyte macrophage colony-stimulating factor (GM-CSF), received no treatment, or no intervention (controls). The degree of ischemia was monitored for 4 weeks using a visual scale. Muscle atrophy and strength were assessed at 4 weeks postoperatively; the mice were then killed. In treated animals, total necrosis of the limb was not found, the weight of the gastrocnemius and quadriceps muscles was significantly higher, functional ability and tissue regeneration were significantly increased, and muscle impairment and adipocyte presence were significantly reduced compared with untreated animals. At inducing angiogenesis, the BMMCs alone was more effective than BMMCs combined with plasmid vector encoding GM-CSF. Treated animals showed increased angiogenesis compared with ischemic untreated ones.

https://doi.org/10.1177/1538574413518119

View Article
2014
2 Reads

Impact of angiogenic therapy in the treatment of critical lower limb ischemia in an animal model.

Vasc Endovascular Surg 2014 Apr 6;48(3):207-16. Epub 2014 Jan 6.

Department of Specialized and General Surgery, Fluminense Federal University (UFF), Niterói, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1538574413518119DOI Listing
April 2014
45 Reads
0.770 Impact Factor

Blue toe syndrome

Journal of the American Podiatry Association

https://publons.com/publon/15614415/

View Article
2005
6 Reads

Covered Versus Bare-Metal Stents for Iliac Occlusive Disease”

http://vascular-endovascular-therapy.imedpub.com/covered-versus-baremetal-stents-for-iliac-occlusive-disease.pdf

View Article
November -0001
3 Reads